Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2021 Nov 11;12:796551. doi: 10.3389/fphar.2021.796551

Corrigendum: Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis

Hongwei Shi 1,2,, Heng Tang 3,, Wen Ai 4, Qingfu Zeng 5, Hong Yang 6, Fengqing Zhu 3, Yunjie Wei 7, Rui Feng 3, Li Wen 3, Peng Pu 3,*, Quan He 3,*
PMCID: PMC8632233  PMID: 34858195

In the original article, there was an error in the Funding section. We neglected to include “National Key R&D Program of China (Grant numbers: 2018YFC1311400, 2018YFC1311404)”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES